Candesartan Cilexetil 8mg

DRUG2 trials

Sponsors

HK inno.N Corporation, Shin Poong Pharmaceutical Co. Ltd.

Conditions

Essential Hypertension

Phase 2

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

HK inno.N CorporationEssential Hypertension

Start: 2014-02-28End: 2015-12-31Target: 384Updated: 2014-04-30

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

CompletedNCT02944734

Shin Poong Pharmaceutical Co. Ltd.Essential Hypertension

Start: 2014-09-30End: 2015-12-31Updated: 2016-11-22

Related Papers

Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial.

2017-07-1910 citations